M. Wortley (London, United Kingdom), R. Gosens (Groningen, Netherlands), L. Uller (Lund, Sweden), P. Kirkham (Wolverhampton (West Midlands), United Kingdom)
Antigen challenge results in specific activation of pathways for arachidonic acid oxygenation
J. Säfholm (Stockholm, Sweden), D. Balgoma (Stockholm, Sweden), A. Fauland (Stockholm, Sweden), C. Gomez (Stockholm, Sweden), J. Kolmert (Stockholm, Sweden), M. Adner (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden)
|  |
Effect of a small natural dietary compound on lung pathology in airway inflammation
A. Chakraborty (Melbourne, Australia), J. Boer (Melbourne, Australia), S. Royce (Melbourne, Australia), K. Wilson (Melbourne, Australia), C. Selomulya (Melbourne, Australia), M. Plebanski (Melbourne, Australia)
|  |
Metformin and pioglitazone inhibited vagus nerve mediated airway hyperreactivity in diet-induced obese rats
Z. Nie (Portland , United States of America), B. Proskocil (Portland , United States of America), D. Jacoby (Portland , United States of America), A. Fryer (Portland , United States of America)
| |
The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha
G. Matschiner (Boston, United States of America), S. Huang (Geneva, Switzerland), S. Constant (Geneva, Switzerland), B. Rattenstetter (Boston, United States of America), H. Gille (Niederzier, Germany), A. Hohlbaum (Ghent, Belgium), B. Koller (Chapell Hill, United States of America), D. Keeling (Gothenburg, Sweden), M. Fitzgerald (Boston, United States of America)
| |
Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide
V. Russell (Verona, Italy), M. Brana (Verona, Italy), D. Pompilio (Verona, Italy), G. Ambrosi (Verona, Italy), F. Andreetta (Verona, Italy), E. Venturini (Verona, Italy), A. Chalidou (London, United Kingdom), M. Manni (Verona, Italy)
| |
Effect of inhaled surfactant enriched with phosphatidylethanolamine on matrix deposition in a murine model of airway inflammation and remodeling.
I. García-Alcudia (Puebla, Mexico), L. Vazquez De Lara (Puebla, Mexico), I. García-Mendoza (Puebla, Mexico), Y. Díaz Gómez (Puebla, Mexico), B. Tlatelpa-Romero (Puebla, Mexico), N. Fernández-Tamayo (Puebla, Mexico), M. García-Carrasco (Puebla, Mexico), F. Vazquez De Lara (New York, United States of America)
| |
Mucus rheology and ciliary beating coordination
M. Jory (Montpellier, France), C. Blanc (Montpellier, France), A. Fort (Montpellier, France), L. Casanellas (Montpellier, France), I. Vachier (Montpellier, France), A. Bourdin (Montpellier, France), G. Massiera (Montpellier, France)
| |
Small airway reactivity is not altered in precision-cut lung slices from a bleomycin mouse model of airway fibrosis
M. Lam (Melbourne, Australia), V. Mao (Melbourne, Australia), C. Samuel (Melbourne, Australia), J. Bourke (Melbourne, Australia), S. Royce (Melbourne, Australia)
| |
Nonclinical safety profiles of DS-1515, a novel oral PI3Kd inhibitor.
K. Yabe (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Mori (Tokyo, Japan)
| |
ADME properties of a novel PI3Kd inhibitor, DS-1515, in preclinical studies
Y. Nishiya (Tokyo, Japan), T. Honda (Tokyo, Japan), K. Itokawa (Tokyo, Japan), O. Ando (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan)
| |
Pharmacological properties of a novel PI3Kd inhibitor, DS-1515
K. Wakita (Tokyo, Japan), K. Koyama (Tokyo, Japan), S. Nakayama (Tokyo, Japan), Y. Nishiya (Tokyo, Japan), P. Chopra (Gurgaon, India), M. Seth (Gurgaon, India), P. Chabbra (Gurgaon, India), P. Srivastava (Gurgaon, India), A. Kumar (Gurgaon, India), M. Diwan (Gurgaon, India), K. Morimoto (Tokyo, Japan), M. Suzuki (Tokyo, Japan)
| |
Cytotoxicity of liposome-encapsulated polyinosinic-polycytidylic acid in primary human macrophages is only partially related to interferon-ß
N. Dauletbaev (Montreal, Canada), A. Dintakurti (Montreal, Canada), Y. Choi (Montreal, Canada), M. Cammisano (Montreal, Canada), W. Viricel (Montreal, Canada), J. Leblond (Montreal, Canada), L. Lands (Montreal, Canada)
| |
Cyclic AMP compartments drive airway epithelial-to-mesenchymal transition (EMT)
M. Schmidt (Groningen, Netherlands), H. Zuo (Groningen, Netherlands), R. & Development Section, N. Heart & Lung Institute, I. College London, L. , U. , L. G. Gregory (l.gregory@imperial.ac.uk / Inflammation, R. & Development Section, N. Heart & Lung Institute, I. College London, L. , U. , J. Vuononvirta (j.vuononvirta@imperial.ac.uk / Inflammation, R. & Development Section, N. Heart & Lung Institute, I. College London, L. , U. , R. Oliver (r.oliver@imperial.ac.uk / Inflammation, R. & Development Section, N. Heart & Lung Institute, I. College London, L. , U. , J. E. Pease (j.pease@imperial.ac.uk / Inflammation, R. & Development Section, N. Heart & Lung Institute, I. College London, L. , U. , M. F. Krummel (matthew.krummel@ucsf.edu / Department of Pathology, U. of California, S. Francisco, P. Ave, S. Francisco, C. , U. Francisco), L. M. Carlin (l.carlin@imperial.ac.uk / Cancer Research UK Beatson Institute, G. Estate, B. , G. , U. , C. M. Lloyd (c.lloyd@imperial.ac.uk / Inflammation, R. & Development Section, N. Heart & Lung Institute, I. College London, L. , U.
| |
Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma
A. De Brito Léia (são paulo, Brazil), T. Santos (são paulo, Brazil), K. Herculano (são paulo, Brazil), C. Alves (são paulo, Brazil), . Oliveira (são paulo, Brazil), S. Soares (são paulo, Brazil), M. Rodrigues (são paulo, Brazil), . Aimbire (são paulo, Brazil), R. Vieira (são paulo, Brazil), A. Franco (são paulo, Brazil), A. Oliveira (são paulo, Brazil)
| |
A fluid secretion assay using nasal organoids
G. Amatngalim (Utrecht, Netherlands), L. Rodenburg (Utrecht, Netherlands), J. Brunsveld (Utrecht, Netherlands), E. Kruisselbrink (Utrecht, Netherlands), K. Van Der Ent (Utrecht, Netherlands), J. Beekman (Utrecht, Netherlands)
| |
Low concentration of phenol in medical solutions can induce bronchoconstriction and toxicity in murine, rat and human lungs.
G. Balakirski (Aachen, Germany), J. Krabbe (Aachen, Germany), T. Schettgen (Aachen, Germany), A. Rieg (Aachen, Germany), T. Schröder (Aachen, Germany), J. Spillner (Aachen, Germany), S. Kalverkamp (Aachen, Germany), T. Braunschweig (Aachen, Germany), S. Kintsler (Aachen, Germany), I. Krüger (Wuerselen, Germany), E. Breuer (Wuerselen, Germany), C. Martin (Aachen, Germany)
| |
Development of a new calcilytic for the treatment of inflammatory lung disease
P. Yarova (Cardiff, United Kingdom), M. Schepelmann (Cardiff, United Kingdom), S. Ferla (Cardiff, United Kingdom), P. Huang (Cardiff, United Kingdom), V. Telezhkin (Newcastle upon Tyne, United Kingdom), E. Kidd (Cardiff, United Kingdom), W. Ford (Cardiff, United Kingdom), K. Broadley (Cardiff, United Kingdom), J. Ward (London, United Kingdom), C. Corrigan (London, United Kingdom), P. Kemp (Cardiff, United Kingdom), A. Brancale (Cardiff, United Kingdom), D. Riccardi (Cardiff, United Kingdom)
| |
The acute effect of inhaled salbutamol and ipratropium on microvascular function
K. Chauhan (London, United Kingdom), H. Al-Rubaye (London, United Kingdom), M. Arzim (London, United Kingdom), V. Osman (London, United Kingdom), E. Baker (London, United Kingdom), H. Fok (London, United Kingdom), S. Ruickbie (London, United Kingdom), D. Burrage (London, United Kingdom)
| |
Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma
L. Calzetta (Rome, Italy), M. Matera (Naples, Italy), J. Ora (Rome, Italy), F. Facciolo (Rome, Italy), M. Cazzola (Rome, Italy), P. Rogliani (Rome, Italy)
| |